Concepedia

Publication | Open Access

Long-term Outcomes of Helper Peptide Vaccination for Metastatic Melanoma

33

Citations

35

References

2015

Year

Abstract

Helper peptide vaccination is associated with improved overall survival among patients with metastatic melanoma. These data support a randomized prospective trial of the 6MHP vaccine.

References

YearCitations

Page 1